A study for a 51 year old man who takes Meloxicam, Androgel, Cymbalta, Morphine, Abilify - from FDA reports


Summary

772 males aged 51 (±5) who take the same drugs are studied. This is a personalized study for a 51 year old male patient who has Low Testosterone, Radiculitis, Major Depression. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Mar, 20, 2017

772 males aged 51 (±5) who take Meloxicam, Androgel, Cymbalta, Morphine, Abilify are studied.


Number of reports submitted per year:

Meloxicam, Androgel, Cymbalta, Morphine, Abilify for a 51-year old man.

Information of the patient in this study:

  • Age: 51
  • Gender: male
  • Conditions: Low Testosterone, Radiculitis, Major Depression
  • Drugs taken:
    • Meloxicam (meloxicam)
    • Androgel (testosterone)
    • Cymbalta (duloxetine hydrochloride)
    • Morphine (morphine sulfate)
    • Abilify (aripiprazole)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • back pain
  • nausea
  • fall
  • heart attack
  • pain in extremity
  • feeling abnormal
  • aspartate aminotransferase increased
  • weakness
  • hallucinations
  • blood bilirubin increased
1 - 6 months:
  • nausea and vomiting
  • weight increased
  • hypoglycemia
  • erection problems
  • nausea
  • diabetic neuropathy
  • type 2 diabetes
  • diarrhea
  • skin candida
  • high blood cholesterol
6 - 12 months:
  • deep venous thrombosis
  • pulmonary embolism
  • heart attack
  • erection problems
  • acute myocardial infarction
  • agitation
  • hallucinations
  • dental caries
  • drug abuse and dependence
  • constipation
1 - 2 years:
  • type 2 diabetes
  • sleep apnea syndrome
  • weight loss
  • rhabdomyolysis
  • stroke
  • nausea and vomiting
  • acute myocardial infarction
  • heart attack
  • mental status changes
  • pain
2 - 5 years:
  • deep venous thrombosis
  • pulmonary embolism
  • heart attack
  • stroke
  • headache
  • weight increased
  • acute myocardial infarction
  • coronary heart disease
  • suicidal ideation
  • cardiac disorder
5 - 10 years:
  • stroke
  • chest pain
  • application site rash
  • headache
  • heart attack
  • drug ineffective
  • impaired gastric emptying
  • weakness
  • rash pruritic
  • insomnia
10+ years:
  • white blood cell count increased
  • coronary artery occlusion
  • heart attack
not specified:
  • pain
  • fatigue
  • nausea
  • stress and anxiety
  • drug ineffective
  • depression
  • nausea and vomiting
  • type 2 diabetes
  • weakness
  • diarrhea

Top conditions involved for these people *:

  • Depression (174 people, 22.54%)
  • Pain (166 people, 21.50%)
  • High Blood Pressure (78 people, 10.10%)
  • Blood Testosterone Decreased (75 people, 9.72%)
  • Stress And Anxiety (62 people, 8.03%)

Top co-used drugs for these people *:

  • Lyrica (95 people, 12.31%)
  • Neurontin (92 people, 11.92%)
  • Nexium (72 people, 9.33%)
  • Ambien (70 people, 9.07%)
  • Seroquel (69 people, 8.94%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Morphine, Cymbalta, Major depression, Abilify, Androgel, Low testosterone, Meloxicam, Radiculitis

You may be interested in these reviews

More reviews for: Morphine, Cymbalta, Major depression, Abilify, Androgel, Low testosterone, Meloxicam, Radiculitis